Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : BIOTECHNOLOGY
BIOCON LTD.
Biocon Ltd.
NSE: BIOCON | BSE: 532523
Strong Performer, Getting Expensive
Download real time
394.65
4.20
(
1.08
%)
New 52W High today
18.2M
NSE+BSE Volume
High volume today
NSE
16 Jul, 2025 3:31 PM (IST)
Watchlist
Portfolio
Alert
Share
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
My Notes
Excel Connect
US FDA Approval
Biocon gets US FDA approval for Kirsty insulin drug with annual sales of $1.9 billion
See details
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Biocon Ltd. News, Corporate filings and Earnings/Conference Calls
Keep track of all breaking news and updates on Biocon Ltd. from all sources in a single place.
All
News
Earnings Calls
Corporate Announcements
Research Reports
Load latest
Is Biocon Ltd. worth buying?
721 Votes:
Buy
75.03%
Sell
16.23%
Hold
8.74%
BUY
SELL
HOLD
RESEARCH REPORTS
Buy
SEE REPORTS >
03 May 2025
pdf
Biocon Ltd.
by Axis Direct
| Target:
351
Target met
Buy
SEE REPORTS >
01 Feb 2025
pdf
Biocon Ltd.
by Axis Direct
| Target:
405
| Upside:
2.62%
All reports of BIOCON